CLEARSIDE BIOMEDICAL INC (CLSD) Stock Cash Flow
NASDAQ:CLSD - Nasdaq - US1850631045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -30.81M | -34.35M | -32.48M | -32.95M | 380.00K | |||
| Depreciation Amortization | 283.00K | 226.00K | 67.00K | 150.00K | 180.00K | |||
| Change In Working Capital | -1.48M | -1.68M | 720.00K | 11.24M | -15.34M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 9.33M | 11.11M | 13.56M | 8.20M | 4.06M | |||
| OPERATING CASH FLOW | -22.68M | -24.70M | -18.14M | -13.37M | -10.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -929.00K | -977.00K | -1.78M | -250.00K | 0.00 | |||
| Other Investing Activity | N/A | 339.00K | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -590.00K | -638.00K | -1.78M | -250.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 27.00K | 13.91M | 98.00K | 700.00K | 23.78M | |||
| Other Financing Activity | 1.51M | 2.53M | 316.00K | 30.64M | N/A | |||
| FINANCING CASH FLOW | 1.54M | 16.44M | 414.00K | 31.33M | 23.78M | |||
| CHANGE IN CASH | -21.73M | -8.90M | -19.50M | 17.71M | 13.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.68M | -24.70M | -18.14M | -13.37M | -10.73M | |||
| Capital Expenditure | -929.00K | -977.00K | -1.78M | -250.00K | 0.00 | |||
| FREE CASH FLOW | -23.61M | -25.68M | -19.91M | -13.62M | -10.73M | |||
All data in USD